Stock Traders Purchase Large Volume of Paysign Call Options (NASDAQ:PAYS)

Paysign, Inc. (NASDAQ:PAYS - Get Free Report) was the target of unusually large options trading on Wednesday. Stock traders acquired 2,310 call options on the company. This represents an increase of approximately 1,032% compared to the typical daily volume of 204 call options.

Paysign Stock Performance

PAYS stock traded up $0.08 during trading on Thursday, reaching $4.43. 1,283,949 shares of the company traded hands, compared to its average volume of 221,599. Paysign has a 12 month low of $1.80 and a 12 month high of $5.59. The business has a 50 day simple moving average of $2.60 and a 200 day simple moving average of $2.82. The company has a market capitalization of $240.19 million, a price-to-earnings ratio of 29.53 and a beta of 0.23.

Paysign (NASDAQ:PAYS - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.01. Paysign had a return on equity of 30.64% and a net margin of 14.28%. The company had revenue of $18.60 million for the quarter, compared to the consensus estimate of $17.49 million. As a group, research analysts forecast that Paysign will post 0.21 EPS for the current year.

Insiders Place Their Bets

In other Paysign news, Director Daniel R. Henry bought 19,800 shares of Paysign stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $3.42 per share, for a total transaction of $67,716.00. Following the completion of the purchase, the director now directly owns 99,800 shares in the company, valued at approximately $341,316. This trade represents a 24.75% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 22.40% of the company's stock.

Institutional Investors Weigh In On Paysign

Institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its position in Paysign by 51.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 267,899 shares of the company's stock valued at $809,000 after purchasing an additional 90,702 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Paysign by 11.0% in the fourth quarter. Renaissance Technologies LLC now owns 1,501,622 shares of the company's stock worth $4,535,000 after acquiring an additional 149,200 shares in the last quarter. 1248 Management LLC acquired a new stake in Paysign in the fourth quarter worth about $2,778,000. JPMorgan Chase & Co. boosted its holdings in Paysign by 164.1% in the third quarter. JPMorgan Chase & Co. now owns 63,247 shares of the company's stock worth $232,000 after acquiring an additional 39,299 shares in the last quarter. Finally, Topline Capital Management LLC acquired a new stake in Paysign in the fourth quarter worth about $16,946,000. Institutional investors own 25.89% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on PAYS. LADENBURG THALM/SH SH raised their price target on Paysign from $7.25 to $8.25 and gave the company a "buy" rating in a research note on Friday, May 9th. Barrington Research restated an "outperform" rating and set a $7.00 price target on shares of Paysign in a research note on Wednesday, March 26th. DA Davidson raised their price target on Paysign from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Finally, Lake Street Capital raised their price target on Paysign from $6.00 to $7.00 and gave the company a "buy" rating in a research note on Friday, May 9th.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.